Deferiprone Modulates in Vitro Responses by Peripheral Blood T Cells From Control and Relapsing–remitting Multiple Sclerosis Subjects

International Immunopharmacology - Netherlands
doi 10.1016/j.intimp.2011.07.007
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Intestinal Permeability in Relapsing-Remitting Multiple Sclerosis

Neurotherapeutics
NeurologyPharmacology
2017English

Progressive Multifocal Leukoencephalopathy and Relapsing-Remitting Multiple Sclerosis

Archives of Neurology
2009English

Cerebrovascular Reactivity and Disease Activity in Relapsing-Remitting Multiple Sclerosis

Advances in Clinical and Experimental Medicine
BiochemistryMedicineGeneticsMolecular Biology
2020English

Immunometabolic Profiling of T Cells From Patients With Relapsing-Remitting Multiple Sclerosis Reveals an Impairment in Glycolysis and Mitochondrial Respiration

Metabolism: Clinical and Experimental
EndocrinologyMetabolismDiabetes
2017English

Disease-Modifying Therapies in Relapsing–remitting Multiple Sclerosis

Neuropsychiatric Disease and Treatment
PsychiatryMental HealthBiological Psychiatry
2010English

Stressful Events Increase Exacerbations in Relapsing-Remitting Multiple Sclerosis

BMJ
2003English

Relapsing-Remitting Multiple Sclerosis and Human Herpesvirus 6 Active Infection

Archives of Neurology
2004English

Natalizumab: A New Treatment for Relapsing Remitting Multiple Sclerosis

Therapeutics and Clinical Risk Management
Chemical HealthPharmacologySafetyMedicineToxicologySafety ResearchPharmaceutics
2007English

Metabolites Predict Lesion Formation and Severity in Relapsing-Remitting Multiple Sclerosis

Multiple Sclerosis
Neurology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy